As SOX7 negatively regulates the Wnt/β-catenin signaling pathway by impeding the transcriptional machinery of β-catenin/TCF/LEF-1, inactivation of SOX7 may be associated with the pathogenesis of cancers, e.g., endometrial cancer and prostate cancer [14,15]. Here, SOX7 is linked to prostate cancer.